common.study.topics.clinical

Dosing Intervals of Opioid Medication for Chronic Pain

common.study.values.description

Dosing Intervals of Opioid Medication for Chronic Pain

This study is to determine the feasibility of an n-of-1, randomized, double blind, placebo controlled case series to examine effects of extended release opioids when used at intervals shorter than recommended by the manufacturer by people with chronic pain.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Extended Release Opioid Formulation, Shortened Intervals

Extended release opioid, individualized total daily dose, dosing interval is less than every 12 hours

Drug - Extended Release Opioid Formulation, Standard intervals

Extended release opioid, individualized total daily dose, dosing interval is every 12 hours

Drug - Placebo oral tablet

Lactose pill manufactured to mimic extended release opioid formulation

participant.views.study.view.additional

participant.views.study.view.scientific-title

Examining the Relationship Amongst Opioid Subjective Effects and Pharmacokinetics of Extended Release Opioids at Shortened Dosing Intervals in Patients With Chronic Pain: a Randomized, Blinded, N-of-1 Case Series Feasibility Study

common.study.values.clinical-trial-id

NCT04132011

participant.views.study.view.id

elYn6a